SHUO MA, M.D., PH.D.
Hematology & Oncology Physician · CHICAGO, IL
Individual Active NPI 1659564938
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 554 | 44,985 | $5,344,055 | $1,532,070 | $1,212,651 |
| 2023 | 709 | 95,436 | $12,740,179 | $3,218,137 | $2,554,296 |
| 2022 | 756 | 150,075 | $17,939,479 | $4,959,658 | $3,946,957 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 4,225 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 3,960 | $50 | $40 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,670 | $45 | $36 |
| J1453 | Injection, fosaprepitant, 1 mg | 2,250 | $0 | $0 |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,470 | $21 | $16 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 887 | $132 | $96 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 516 | $17 | $13 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 370 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 260 | $1 | $1 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 230 | $0 | $0 |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 197 | $187 | $143 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 195 | $81 | $65 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | — | IL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Illinois
- NPI 1871239582
- NPI 1629603139
- NPI 1033798905
- NPI 1285995266
- NPI 1407899198
- NPI 1467846360
- NPI 1881156289
- NPI 1831295211
See all Hematology & Oncology Physician providers in Illinois →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.